GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Imexpharm Corp (STC:IMP) » Definitions » Other Operating Expense

Imexpharm (STC:IMP) Other Operating Expense : ₫104,411 Mil (TTM As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Imexpharm Other Operating Expense?

Imexpharm's Other Operating Expense for the three months ended in Mar. 2024 was ₫45,976 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₫104,411 Mil.

Imexpharm's quarterly Other Operating Expense increased from Sep. 2023 (₫0 Mil) to Dec. 2023 (₫58,435 Mil) but then declined from Dec. 2023 (₫58,435 Mil) to Mar. 2024 (₫45,976 Mil).

Imexpharm's annual Other Operating Expense increased from Dec. 2021 (₫127,032 Mil) to Dec. 2022 (₫187,937 Mil) and increased from Dec. 2022 (₫187,937 Mil) to Dec. 2023 (₫193,984 Mil).


Imexpharm Other Operating Expense Historical Data

The historical data trend for Imexpharm's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imexpharm Other Operating Expense Chart

Imexpharm Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 146,771.64 138,397.30 127,032.25 187,936.58 193,984.23

Imexpharm Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48,095.90 - - 58,434.93 45,976.17

Imexpharm Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫104,411 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Imexpharm Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Imexpharm's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Imexpharm (STC:IMP) Business Description

Traded in Other Exchanges
N/A
Address
4 Road 30/04 Street Ward 1, Cao Lanh City, Dongthap, VNM
Imexpharm Corp is engaged in the manufacture, import, export, and trade of pharmaceuticals and medicinal chemical products. Its products include oral and injective antibiotic, digestion, central nervous system, cardiovascular, diabetes, musculoskeletal system, respiratory system, analgesic-anti-inflammatory, anti-allergy, ophthalmology, external drugs, and anti-parasitic, as well as vitamins and minerals.

Imexpharm (STC:IMP) Headlines

No Headlines